NCT05238233View on ClinicalTrials.gov

Wearing-Off Period of Pharmacological Dilation and Anisocoria

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions
Anisocoria
Interventions
DRUG

Tropicamide

One drop will be given to participants

DRUG

1% Pilocarpine

One drop will be given to participants

DRUG

Proparacaine Hydrochloride

One drop will be given to participants

DEVICE

Tono pen AVIA

Participant intraocular pressures measured

DEVICE

VG4 Gonio

Participant iridocorneal angle measured

DEVICE

Reichert phoropter

Participant screened for hyperopia \>+1 diopter

Trial Locations (1)

29605

Prisma Health, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER